Antares Pharma, Inc. (ATRS)

Operating Expenses

$112.69M

TTM · Period ending: · USD

ATRS logo

ATRS Operating Expenses

Latest reported$112.69M
ATRS TTM Operating Expenses ($3.90M → $112.69M)
High-resolution chart · PNG

ATRS operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
5,401,221
3,901,221
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.